{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:31:37Z","timestamp":1768447897415,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1124\/dmd.106.011551","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T03:24:34Z","timestamp":1164770674000},"page":"283-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Metabolism of MK-0524, a Prostaglandin D2 Receptor 1 Antagonist, in Microsomes and Hepatocytes from Preclinical Species and Humans"],"prefix":"10.1016","volume":"35","author":[{"given":"Brian J.","family":"Dean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Victoria Silva","family":"Elipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Qing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Soli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald B.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindhu","family":"Karanam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.106.011551_bib1","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","article-title":"Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man","volume":"269","author":"Bosma","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.106.011551_bib2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0024-3205(95)02073-R","article-title":"Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation","volume":"57","author":"Burchell","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/dmd.106.011551_bib3","article-title":"The pharmacokinetics and disposition of MK-0524 a DP1 antagonist, in rats, dogs and monkeys","author":"Chang","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.106.011551_bib4","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.106.011551_bib5","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.011551_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0090-6980(79)90055-8","article-title":"Prostaglandins contribute to the vasodilation induced by nicotinic acid","volume":"17","author":"Eklund","year":"1979","journal-title":"Prostaglandins"},{"key":"10.1124\/dmd.106.011551_bib7","first-page":"267","article-title":"Improvement of the nicotinic acid test in the diagnosis of Gilbert\u2019s syndrome by pretreatment with indomethacin","volume":"32","author":"Gentile","year":"1985","journal-title":"Hepatogastroenterology"},{"key":"10.1124\/dmd.106.011551_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-3565(25)10294-2","article-title":"Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs","volume":"264","author":"Jin","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.106.011551_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/toxsci\/61.1.49","article-title":"Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac","volume":"61","author":"King","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.106.011551_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knoop","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.106.011551_bib11","first-page":"1096","article-title":"Glucuronidation of 1-hydroxypyrene by human liver microsomes and human UDP-glucuronosyltransferases UGT1A6, UGT1A7, and UGT1A9: development of a high-sensitivity glucuronidation assay for human tissue","volume":"29","author":"Luukkanen","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.106.011551_bib12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J Investig Dermatol"},{"key":"10.1124\/dmd.106.011551_bib13","article-title":"In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites","author":"Nicoll-Griffith","year":"2006","journal-title":"Bioorg Med Chem Lettjavascript: AL get(this, \u2019jour\u2019, \u2019Bioorg Med Chem Lett.\u2019)"},{"key":"10.1124\/dmd.106.011551_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0006-2952(93)90538-8","article-title":"Validation and use of cloned, expressed human drug metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions","volume":"46","author":"Remmel","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.106.011551_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.amjcard.2004.04.024","article-title":"Safety and compliance with once-daily niacin extended-release\/lovastatin as initial therapy in the impact of medical subspeciality on patient compliance to treatment (IMPACT) study","volume":"94","author":"Rubenfire","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1124\/dmd.106.011551_bib16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI109385","article-title":"Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism","volume":"63","author":"Shepherd","year":"1979","journal-title":"J Clin Investig"},{"key":"10.1124\/dmd.106.011551_bib17","article-title":"Discovery of a potent and selective PGD2 receptor antagonist [(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524)","author":"Sturino","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.106.011551_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1185\/030079906X89766","article-title":"On behalf of the Nautilus Study Group, 2006. Evaluation of safety and tolerability of prolonged-release nicotonic acid in a usual care setting","volume":"22","author":"Vogt","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/dmd.106.011551_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.amjcard.2003.10.009","article-title":"Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)","volume":"93","author":"Zhao","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624012145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624012145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.106.011551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:26:53Z","timestamp":1739896013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624012145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0090955624012145"],"URL":"https:\/\/doi.org\/10.1124\/dmd.106.011551","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism of MK-0524, a Prostaglandin D2 Receptor 1 Antagonist, in Microsomes and Hepatocytes from Preclinical Species and Humans","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.106.011551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}